DIRECT COST ANALYSIS AND COST EFFECTIVENESS ANALYSIS OF CHRONIC OBSTRUCTION PULMONARY DISEASE IN FATMAWATI PUBLIC HOSPITAL

Author(s)

Anwar Y1, Afdhal AF1, Anggraini Y2
117 August 1945 Jakarta University, Jakarta, Indonesia, 2Pancasila University, Jakarta, Indonesia

OBJECTIVES: Chronic  Obstruction  Pulmonary  Disease (COPD)  is  one  of  the  world causes  of   morbidity and  mortality. Level  of  COPD  seriousness  results  in  the  increasing   number  of  Length Of Stay(LOS)  in  the hospital. This research has been conducted in 2014 to analyse total  direct  cost  and cost  effectiveness analysis by  the combination of ipratropium and salbutamol and  single salbutamol on the  COPD  in  Fatmawati  Public  Hospital  Jakarta.  METHODS: COPD patients who were hospitalized in Fatmawati  Public  Hospital  between 1 January 2010 – 31 March  2014  were grouped according to  the  classification  of  COPD by Indonesian Pulmonary Doctor Association. Study design used was cross sectionaland retrospective. In addition, data were analyzed descriptively and calculating the  Pearson correlation (r) that  was   conducted  on   the  seriousness  level  of   COPD  on  total direct  cost. In addition, cost effectiveness of the combination of ipratropium and salbutamol therapy was compared to single salbutamol therapy on COPD patients. RESULTS: Among 237 patients of COPD, 122 patients with primary diagnosis and 115 patients with accompanying diagnosis. There were 97 patients who met inclusion criteria. The average total direct costs were IDR15,069,927.23. The highest  cost  was  on cost of hospital stay, IDR5,106,409.99 (35,32%), followed by medicament cost IDR4,984,922.86 (32,51%).  There  was  a  very  strong   correlation   (r = 0.876)  between  COPD  seriousness  level   with   the   average   direct   total  costs   per  year  with   or   without comorbidity. COPD  therapy, It has also shown,  that cost  and  effectiveness  were  not  significantly  differed   (p > 0.05) between salbutamol combination and single  salbutamol. CONCLUSIONS: In primary care, disease management should more focused on the holistic assessment and reduction of symptoms. For the future purposes treatment of COPD  should follow the published guidelines for systematic diagnosis of symptoms and health status. This is important to improve the clinical outcome of individual and patients.

Conference/Value in Health Info

2016-09, ISPOR Asia Pacific 2016, Singapore

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PRS7

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×